Genetic Technologies Ltd Cash Flow Reinvestment Rate
Genetic Technologies Ltd cash flow reinvestment rate. Genetic Technologies Ltd (GENE) has a Cash Flow Reinvestment Rate of 0.06x as of June 2011, reinvesting $69.84K (capex $69.84K ) from operating cash flow of $1.12 Million. Explore GENE cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Genetic Technologies Ltd (2007–2011)
Cash flow reinvestment rate of Genetic Technologies Ltd from 2007 to 2011. Historical reinvestment intensity for Genetic Technologies Ltd across 3 annual periods. Explore GENE capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Genetic Technologies Ltd Cash Flow Reinvestment Rate by Year (2007–2011)
Genetic Technologies Ltd cash flow reinvestment rate by year from 2007 to 2011. Year-by-year capital reinvestment analysis for Genetic Technologies Ltd. For the full cash flow conversion analysis, see cash flow conversion of Genetic Technologies Ltd.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2011 | 0.06x | $139.68K | $2.23 Million | $139.68K | ▼ -77.6% |
| 2008 | 0.28x | $118.26K | $423.68K | $118.26K | ▲ +286.6% |
| 2007 | 0.07x | $158.87K | $2.20 Million | $158.87K | — |